top of page
Carbon Logic Biotech

License-out partnership of colorectal cancer molecular diagnostics

Carbon Logic Biotech develops molecular diagnostics, prognostic and predictive tests for colorectal cancer patients. Our molecular diagnostics address unmet medical needs of colorectal cancer patients. These tests are validated using our proprietary RNAseq datasets of formalin-fixed, paraffin-embedded (FFPE) samples. We seek a partner to license out our 3 molecular diagnostics products.

Medical Device:

Apparatus Other products Development China USA Europe

Demand Type:

Looking for licensing partnership


December 30, 2024

Back to Business

bottom of page